Active, not recruitingPHASE1, PHASE2NCT06152237

Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Studying Rett syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Taysha Gene Therapies, Inc.
Principal Investigator
Laura Pisani, M.D.
Taysha Gene Therapies
Intervention
TSHA-102(genetic)
Enrollment
6 enrolled
Eligibility
5-8 years · FEMALE
Timeline
2023 – 2031

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06152237 on ClinicalTrials.gov

Other trials for Rett syndrome

Additional recruiting or active studies for the same condition.

See all trials for Rett syndrome →

← Back to all trials